PROCEPT BioRobotics Investor Relations Material
Latest events
Status Update
PROCEPT BioRobotics
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from PROCEPT BioRobotics Corporation
Access all reports
PROCEPT BioRobotics Corporation is a medical technology company specializing in the development and commercialization of robotic systems for the treatment of urological conditions. The company’s primary focus is on addressing benign prostatic hyperplasia (BPH), offering minimally invasive solutions designed to improve precision, patient outcomes, and recovery times. Its robotic platform combines imaging, robotics, and software to enhance surgical accuracy and efficiency, supporting healthcare providers in delivering advanced care. PROCEPT BioRobotics Corporation is headquartered in Redwood City, California, and its shares are listed on the NASDAQ.
Key slides for PROCEPT BioRobotics Corporation
Q2 2024
PROCEPT BioRobotics Corporation
Status Update
PROCEPT BioRobotics Corporation
Latest articles
)
MSCI: Indexing the World
The story of how MSCI has become the backbone of global finance through its indexes, powering decision-making across trillions in assets.
30 May 2025
)
A Purpose-Built AI Chat for Finance and IR Professionals
Quartr Pro's new AI chat lets IR and finance professionals ask anything across 13,000+ public companies and get instant answers.
27 May 2025
)
Costco Wholesale: The Model of Scalable Simplicity
Costco's rise from warehouse club to retail giant is built on low prices, scale efficiency, and a model designed for lasting customer value.
26 May 2025
Ticker symbol
PRCT
Country
🇺🇸 United States